← Eichor
Study identifier: NCT06676761 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Outcomes of a Novel Technique Minimal Scar Mastectomy

Condition: Breast Cancer Early Stage Breast Cancer (Stage 1-3)  ·  Sponsor: KK Women's and Children's Hospital

PhaseN/A
Planned participants100
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

Nipple sparing mastectomy is oncologically safe and has a good cosmetic outcome. However, nipple sparing mastectomy was conventionally performed with reconstruction. Minimal scar mastectomy (MSM) is a novel technique which could allow women, with non-ptotic breasts, who do not want reconstruction, to conserve their nipple areolar complex (NAC) and avoid the transverse scar associated with modified radical mastectomy. This is the first study on the oncologic and surgical outcomes of MSM.

This description comes directly from the study's public registry record.

Talk to the study team

Geok hoon Lim  ·  96392353  ·  ghlimsg@yahoo.com.sg

Always discuss trial participation with your own doctor first.

Locations (2)

KK Women's and Children's HospitalSingapore, SingaporeRecruiting
KK Women's and Children's HospitalSingapore, SingaporeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06676761